Basic information
- CAS
87626-55-9- Standard SMILES
O=C(O)Cc1cccc2c(=O)cc(-c3ccccc3)oc12- InChIKey
TZZNWMJZDWYJAZ-UHFFFAOYSA-N- Molecular formula
- C17H12O4
- Average molar mass
- 280.27 g/mol
- Monoisotopic mass
- 280.07355886
Overview
Mitoflaxone is a small molecule drug. Mitoflaxone has a monoisotopic molecular weight of 280.07 Da.
Names & identifiers
- Preferred name
- Flavone-8-Acetic Acid
- IUPAC
- 2-(4-oxo-2-phenylchromen-8-yl)acetic acid
- English name
- Mitoflaxone
- Molecular formula
- C17H12O4
- Molecular weight
- 280.27
Names & synonyms
Show more names
Database identifiers
- CAS
87626-55-9- PubChem CID
- 55748
- DTXSID
DTXSID50236534- ChEMBL
CHEMBL443793- UNII
- X230G6E63B
- Nikkaji
- J227.455H
Properties
Computed structural properties
- XLogP
- 3
- Topological polar surface area
- 63.6 Ų
- Hydrogen bond donors
- 1
- Hydrogen bond acceptors
- 4
- Rotatable bonds
- 3
- Heavy atoms
- 21
- Formal charge
- 0
- Complexity
- 448
Experimental & physicochemical properties
Solubility
Water < 0.1 (mg/mL)
0.1 N NaOH ~20 (mg/mL)
0.1 N HCl < 0.1 (mg/mL)
0.1 M NaHCO3 < 0.3 (mg/mL)
95% EtOH 1 (mg/mL)
MeOH 1 (mg/mL)
Physicochemical properties
- Melting point
- 234 °C · 234 °C(Solv: ethanol (64-17-5))
- Boiling point
- 507.9 · 507.9±50.0 °C(Predicted)
- Density
- 1.355 · 1.355±0.06 g/cm3(Predicted)
- pka
- 4.16 · 4.16±0.10(Predicted)
- FDA UNII
- 230 G6E63B · X230G6E63B
- NCI Drug Dictionary
- flavone acetic acid
Chemistry & industry
Pharmacology
MeSH Pharmacological Classification
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.
Substances that inhibit or prevent the proliferation of NEOPLASMS.
Suppliers6 total
Related reactions
Compound notes
Loading…